-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
WWmXEbdjb37w0oTZroAz165sxwH8G4WQmDaZB1g+YSGZPu8gzrDP7tulAW8sUm/x
ZiQLHZS/Hj7UgiOwoQL1kA==
0000885725-02-000050.txt : 20021023
0000885725-02-000050.hdr.sgml : 20021023
20021023134403
ACCESSION NUMBER: 0000885725-02-000050
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20021022
FILED AS OF DATE: 20021023
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
RELATIONSHIP: OWNER
IRS NUMBER: 042695240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
BUSINESS ADDRESS:
STREET 1: ONE BOSTON SCIENTIFIC PL
CITY: NATICK
STATE: MA
ZIP: 01760-1537
BUSINESS PHONE: 5086508000
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: ASPECT MEDICAL SYSTEMS INC
CENTRAL INDEX KEY: 0000886235
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 042985553
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24663
FILM NUMBER: 02795975
BUSINESS ADDRESS:
STREET 1: 141 NEEDHAM STREET
CITY: NEWTON
STATE: MA
ZIP: 02464-1505
BUSINESS PHONE: (617) 559-7857
MAIL ADDRESS:
STREET 1: 141 NEWTON STREET
CITY: NEWTON
STATE: MA
ZIP: 02464-1505
4
1
bos25.htm
FORM 4 10/22/02
SEC Form 4
FORM 4
[ ] Check this box if no longer
subject to Section 16. Form 4 or Form
5 obligations may continue.
See Instruction 1(b). |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility
Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
|
OMB APPROVAL
OMB Number: 3235-0287 Expires: January 31, 2005
Estimated average burden
hours per response. . . . . 0.5 |
1. Name and Address of Reporting Person* Boston Scientific Corporation (Last) (First) (Middle) One Boston Scientific Place
(Street) Natick, MA 01760-1537 (City) (State) (Zip) USA |
2. Issuer Name and Ticker
or Trading Symbol
Aspect Medical Systems, Inc. ASPM 3. I.R.S. Identification
Number of Reporting
Person, if an entity
(voluntary) - |
4. Statement for
(Month/Day/Year)
October 22, 2002
5. If Amendment,
Date of Original
(Month/Year) |
6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
Director X 10% Owner Officer Other
Officer/Other Description 7. Individual or Joint/Group
Filing (Check Applicable Line)
X Individual Filing Joint/Group Filing |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
1. Title of Security
(Instr. 3)
|
2. Transaction Date
(Month/Day/Year) |
3. Transaction
Code
and
Voluntary
Code
(Instr. 8)
Code | V |
4. Securities Acquired (A) or Disposed (D) Of
(Instr. 3, 4, and 5)
Amount | A/D | Price |
5. Amount of
Securities
Beneficially
Owned at
End ofMonth
(Instr. 3 and 4) |
6. Owner-
ship
Form:
Direct(D)
or
Indirect (I)
(Instr. 4) |
7. Nature of
Indirect
Beneficial
Ownership
(Instr. 4) |
Common Stock |
10/21/2002 |
P | |
250,000 | A | $3.4000 |
|
D |
|
Common Stock |
10/22/2002 |
P | |
128,500 | A | $3.4000 |
3,195,672 |
D |
|
|
|
|
|
|
|
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4(b)(v).
(over)
SEC 1474 (3-99) |
Boston Scientific Corporation - October 2002
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) |
1. Title of Derivative Security
(Instr. 3) |
2. Conver-
sion or
Exercise
Price of
Deri-
vative
Security |
3. Transaction
Date
(Month/
Day/
Year) |
4. Transaction
Code
and
Voluntary (V)
Code
(Instr.8)
Code | V |
5. Number of Derivative
Securities Acquired (A)
or Disposed (D) Of
(Instr. 3,4 and 5) |
6. Date Exercisable(DE) and
Expiration Date(ED)
(Month/Day/Year)
(DE) | (ED) |
7. Title and Amount of
Underlying Securities
(Instr. 3 and 4) |
8. Price
of
Derivative
Security
(Instr.5) |
9. Number of
Derivative
Securities
Beneficially
Owned
at End of
Month
(Instr.4) |
10.
Owner-
ship
Form of
Deriv-
ative
Security:
Direct
(D)
or
Indirect
(I) |
11. Nature of
Indirect
Beneficial
Ownership
(Instr.4) |
|
|
|
|
|
|
|
|
|
|
|
Explanation of Responses :
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
See Instruction 6 for procedure.
Potential persons who are to respond to the collection of information contained in this form are not
required to respond unless the form displays a currently valid OMB number. |
Lawrence J. Knopf, Vice President
________________________________ 10-23-2002
** Signature of Reporting Person Date
Boston Scientific Corporation
Page 2
SEC 1474 (3-99) |
-----END PRIVACY-ENHANCED MESSAGE-----